These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17195519)

  • 1. [Optimization of hepatoprotective therapy of viral hepatitis with consideration of neuromediatory link of pathogenesis].
    Sitnikov IG; Maleev VV; Shoshin AA
    Ter Arkh; 2006; 78(11):12-7. PubMed ID: 17195519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [STUDY OF HEPATOPROTECTIVE PROPERTIES OF RNA-CONTAINING DRUG "RN-13" ON THE MODEL OF ACUTE TETRAHLLORMETHANE INDUCED HEPATITIS IN RATS].
    Shulgau Z; Sergazy S; Krivoruchko T; Sagindykova B; Gulyayev A
    Georgian Med News; 2017 Apr; (265):104-109. PubMed ID: 28574392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoprotective activity of Leucas hirta against CCl4 induced hepatic damage in rats.
    Manjunatha BK; Vidya SM; Dhiman P; Pallavi R; Mankani KL
    Indian J Exp Biol; 2005 Aug; 43(8):722-7. PubMed ID: 16121714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatoprotectors prevent the toxic action of cyclophosphamide on the liver of rats with CCl4-induced hepatitis model].
    Rat'kin AV; Saratikov AS; Chuchalin VS; Burkova VN; Frolov VN
    Eksp Klin Farmakol; 2005; 68(2):47-50. PubMed ID: 15934368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of hepatoprotective activity of ethylmethylhydroxypyridine fumarate and lipoate in the experimental toxic hepatitis].
    Semenova EV; Inchina VI
    Eksp Klin Gastroenterol; 2007; (6):122-5, 131. PubMed ID: 18416106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral hepatitis at a crossroad.
    Lok AS; Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1261-3. PubMed ID: 22537431
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatoprotectors in addictive medicine].
    Sivolap IuP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5 Pt 2):49-50. PubMed ID: 22951798
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatoprotective effects of gamma-L-glutamylhistamine].
    Zheltukhina GA; Nebol'sin VE; Krzhechkovskaia VV; Evstigneeva RP
    Vopr Med Khim; 2002; 48(5):443-9. PubMed ID: 12498085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferons in the management of viral hepatitis.
    Zein NN
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The joint use of prednisolone and phospholipid-containing hepatoprotectors in experimental chronic hepatitis].
    Vengerovskiĭ AI; Golovina EL; Kovalenko MIu; Chuchalin VS; Saprykina EV; Sosnina NV; Burkova VN; Saratikov AS
    Eksp Klin Farmakol; 1999; 62(2):28-30. PubMed ID: 10340125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral hepatitis after liver transplantation. Which immunosuppressive drugs should be recommended?
    Ciesek S; Manns MP; Wedemeyer H
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):337-50. PubMed ID: 18043552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and hepatitis C in 2009.
    Marcellin P
    Liver Int; 2009 Jan; 29 Suppl 1():1-8. PubMed ID: 19207959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy of hepatoprotectors and cytochrome P-450 inducers in correcting the functional activity of the hepatocyte microsomal system in an acute lesion of the liver in prepuberty].
    Khakimov ZZ; Rakhmanov AKh
    Eksp Klin Farmakol; 1992; 55(4):16-7. PubMed ID: 1458177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatoprotective effect of plant preparations].
    Katikova OIu; Kostin IaV; Tishkin VS
    Eksp Klin Farmakol; 2002; 65(1):41-3. PubMed ID: 12025784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of the effect of hepatoprotectors and inducers on cardiogreen pharmacokinetics in acute toxic hepatitis in the prepuberty period].
    Khakimov ZZ; Rakhmanov AKh
    Eksp Klin Farmakol; 1994; 57(6):57-9. PubMed ID: 7756967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatoprotective effect of 2-demethoxycarbonyl-2-ethoxycarbonyl-11-deoxymisoprostol].
    Sapozhnikova TA; Zarudiĭ FS; Baschenko NZh; Makara NS; Khisamutdinova RIu; Gabdrakhmanova SF; Ivanova NA; Nazarov VS
    Eksp Klin Farmakol; 2007; 70(4):30-1. PubMed ID: 18078039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of protective action of bicyclol against CCl-induced liver injury in mice.
    Liu GT; Li Y; Wei HL; Zhang H; Xu JY; Yu LH
    Liver Int; 2005 Aug; 25(4):872-9. PubMed ID: 15998439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoprotective and antifibrotic effects of sodium molybdate in a rat model of bile duct ligation.
    Ale-Ebrahim M; Eidi A; Mortazavi P; Tavangar SM; Tehrani DM
    J Trace Elem Med Biol; 2015 Jan; 29():242-8. PubMed ID: 25084733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hepatitis B and C -- current standards].
    Zeuzem S
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S57-9. PubMed ID: 15368169
    [No Abstract]   [Full Text] [Related]  

  • 20. [The efficacy of hepatoprotective agents in experimental chronic hepatitis].
    Saratikov AS; Vengerovskiĭ ; Baturina NO; Chuchalin VS
    Eksp Klin Farmakol; 1996; 59(1):24-6. PubMed ID: 8704626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.